The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
CBLL · Healthcare · Narrow moat
On the watchlist
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
BIOE · Healthcare · Narrow moat
On the watchlist
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | CBLL | BIOE | IMAX | ACAD |
|---|---|---|---|---|
| Moat Score (0–100) | 61 (highest) | 61 (highest) | 61 (highest) | 61 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 70 | 65 | 80 (highest) | 80 (highest) |
| Pricing power | 100 (highest) | 57 | 66 | 98 |
| Returns on capital | — | — | 35 (highest) | 4 |
| Balance-sheet safety | 28 | 99 | 51 | 100 (highest) |
| Capital allocation | 47 | 24 | 74 (highest) | 24 |
| No price data | No price data | 167% above value if growth stopped today | No price data | |
| Market cap | $634M | $10.3M | $2.3B | $4.2B |
| Moat tier | Narrow moat | Narrow moat | Narrow moat | Narrow moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2025 |